Chapter 1 Ergot Alkaloids
- 1 January 1990
- book chapter
- Published by Elsevier
- Vol. 38, 1-156
- https://doi.org/10.1016/s0099-9598(08)60238-2
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- Hypothalamo-hypophyseal-gonadal function in the rat following administration of the novel and selective D-1 agonist CY 208-243Cellular and Molecular Life Sciences, 1988
- Human platelet 5-hydroxytryptamine receptors: Binding of [3H]-lysergic acid diethylamide (LSD). Effects of chronic neuroleptic and antidepressant drug administrationCellular and Molecular Life Sciences, 1988
- CY 208–243: A unique combination of atypical opioid antinociception and D1 dopaminomimetic propertiesLife Sciences, 1988
- Dual action on central dopamine function of transdihydrolisuride, a 9, 10-dihydrogenated analogue of the ergot dopamine agonist lisurideLife Sciences, 1983
- Incorporation of α-aminobutyric acid into ergostine byClaviceps purpureaCellular and Molecular Life Sciences, 1981
- Incorporation of L-[U-14C]leucine into ergosine by cell-free extracts of Clavicepspurpurea (FR.) tulBiochemical and Biophysical Research Communications, 1981
- A blocked mutant ofClaviceps purpurea accumulating chanoclavine-I-aldehydeCellular and Molecular Life Sciences, 1980
- Effects of (8β)-8-[(Methylthio)methyl]-6-propylergoline on dopaminergic function and brain dopamine turnover in ratsLife Sciences, 1979
- Roquefortine and isofumigaclavine A, metabolites fromPenicillium roquefortiCellular and Molecular Life Sciences, 1976
- On the biosynthesis of peptide ergot alkaloidsCellular and Molecular Life Sciences, 1974